Vedolizumab for Immune Mediated Colitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is an open label randomized trial to evaluate the efficacy and treatment duration with vedolizumab to patients with immune mediated colitis. The trial will include 82 patients randomized into two arms, either standard treatment with prednisolone (plus infliximab in severe cases) or vedolizumab treatment up front.
Epistemonikos ID: c61415f50b190bbbc8345e1881096c3c75deb935
First added on: May 08, 2024